InvestorsHub Logo
Followers 466
Posts 26939
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Wednesday, 04/07/2010 9:46:46 AM

Wednesday, April 07, 2010 9:46:46 AM

Post# of 22684
Arena Pharmaceuticals(ARNA)
Drug/indication: Lorcaserin for obesity
Approval decision date: Oct. 22
Lorcaserin is one of three obesity drugs currently under review by the FDA. Regulators have not yet indicated whether Arena will be required to bring lorcaserin in front of an advisory panel.

http://www.thestreet.com/story/10719163/12/14-biotech-stocks-facing-fda-approval.html


surf's up......crikey